BeStock  
Stocks › Biotechnology › PTGX

Protagonist Therapeutics PTGX

US equityMarket cap rank #1605Biotechnology
$121.40 −$2.62 (-2.11%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $121.40 0.00%
Open$123.41
Prev close$124.02
Day range$120.15 – $125.91
Volume600.7K
Market cap$7.92B
P/E (TTM)25.7
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership122.4%+1.97 pts vs. prior quarter
Institutions holding460+30 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
Short interest15.83% of floatDays to cover 16.9 · as of 30 Oct 2026
Short-sale volume share21.4%5-day average of daily volume

Short-sale volume as % of daily volume

13%21%28%36%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.50M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$2.0MSuper−$508.5KBig−$7.9MMid−$7.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 44.4% of shares outstanding.

Largest holders

  • BlackRock15.07%
  • Farallon Capital Management, L.L.C.9.73%
  • RTW Investments, LP7.75%
  • UBS Asset Management6.22%
  • Vanguard Portfolio Management, LLC5.62%
  • State Street Global Advisors5.33%
  • Wellington Management Group5.23%
  • Vanguard Capital Management, LLC4.44%

By investor type

  • Mutual Fund82.73%
  • Hedge Fund25.61%
  • VC/PE Fund5.85%
  • Public Company4.86%
  • Private Company1.35%
  • Government Pension Fund1.16%
  • Individual/Insider0.59%
  • Family Office/Trust0.42%

Reported short interest has risen from 12.04% to 15.83% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
UBS Asset Management Mutual Fund 2026/Q3 +554,015 6.2%
FMR Mutual Fund 2026/Q3 +403,349 1.6%
Stephens Investment Management Group, LLC Mutual Fund 2026/Q3 +186,670 0.7%
State Street Global Advisors Mutual Fund 2026/Q3 +157,713 5.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +118,193 0.5%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +99,352 0.3%
Ranger Investment Management, L.P. Mutual Fund 2026/Q3 +82,362 0.1%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +76,967 0.1%
BlackRock Mutual Fund 2026/Q3 +528,468 15.9%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +484,165 3.3%
Putnam LLC Mutual Fund 2026/Q3 +382,425 0.7%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +296,101 1.4%
Stephens Investment Management Group, LLC Mutual Fund 2026/Q3 +281,832 0.4%
Lord, Abbett & Co. LLC Mutual Fund 2026/Q3 +235,535 0.6%
State Street Global Advisors Mutual Fund 2026/Q3 +204,805 5.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Sep 2026 Asif Ali Chief Financial Officer Derivative Exercise and Sale -58,629 $141.78 2,569
9 Sep 2026 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -125,000 $146.18 286,926
2 Sep 2026 Dinesh Patel CEO, President, Secretary & Director Other Disposition -510 – 286,926
10 Aug 2026 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -100,000 $149.11 287,436
22 Jun 2026 William Waddill Independent Director Derivative Exercise and Sale -9,000 $117.94 5,130
9 Jun 2026 William Waddill Independent Director Derivative Exercise and Sale -9,000 $107.68 5,130
28 May 2026 William Waddill Independent Director Derivative Exercise and Sale -9,000 $99.64 5,130
11 May 2026 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -75,000 $100.12 287,436
7 May 2026 Bryan Giraudo Independent Director Open Market Disposition -23,130 $100.07 10,000
6 May 2026 Bryan Giraudo Independent Director Derivative Exercise and Sale -36,000 $100.14 10,000
22 Apr 2026 Dinesh Patel CEO, President, Secretary & Director Other Disposition -1,460 – 287,436
19 Apr 2026 Asif Ali Chief Financial Officer Open Market Disposition -1,750 $105.47 2,569
25 Mar 2026 Harold Selick Independent Chairperson Derivative Exercise and Sale -24,000 $105.00 58,150
25 Mar 2026 Arturo Molina Chief Medical Officer Derivative Exercise and Sale -15,000 $104.79 13,637
25 Mar 2026 Asif Ali Chief Financial Officer Derivative Exercise and Sale -24,765 $104.24 4,319
24 Mar 2026 Dinesh Patel CEO, President, Secretary & Director Derivative Exercise and Sale -54,700 $101.00 288,896
22 Mar 2026 Dinesh Patel CEO, President, Secretary & Director Other Disposition -50,000 – 288,896
16 Feb 2026 Lewis Williams Independent Director Derivative Exercise and Sale -18,000 $82.42 5,130
5 Feb 2026 William Waddill Independent Director Derivative Exercise and Sale -20,000 $83.68 5,130
26 Jan 2026 Arturo Molina Chief Medical Officer Intent to Sell (Form 144) -5,000 $82.00 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,242,340 15.8% 16.9
15 Oct 2026 10,297,224 15.9% 12.0
30 Sep 2026 9,345,382 14.4% 11.5
15 Sep 2026 8,140,194 12.6% 15.1
31 Aug 2026 7,712,543 11.9% 15.3
14 Aug 2026 7,791,795 12.0% 16.4

Discussion

No comments yet — be the first to weigh in on PTGX.

Sign in to join the discussion.

Scroll to Top